أبدا لم يفت الاوان لكي تبدأ

Slides:



Advertisements
Similar presentations
Agents Used in the Treatment of Hyperlipidemia
Advertisements

Atherosclerosis Focal plaques within the intima containing cholesterol and cholesterol esters (CE) Affects large and medium sized arteries Causes coronary.
Drugs in dyslipidaemias
Department of Pharmacology, LSUHSC,
CHOLESTEROL AND OUR LIVES الدهنيات وحياتنا
Lipids 101 Cardiology Board Review Med-Peds Style!
Drugs and Dyslipidemias (statins and other lipid and atherosclerosis-modifying drugs) October 18, 2006 Frank F. Vincenzi.
Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.
Treatment of Dyslipidemia SDPI CGP Healthy Heart Project March 8, 2006.
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 50 Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol.
Anti-Hypercholesterolemic Agents  Biosynthesis and Metabolism of Cholesterol  What is arteriosclerosis? - Link between arteriosclerosis and cholesterol.
ANTILIPEMICS LILLEY, READING & WORKBOOK: CHAP 28 Cardiovascular System.
Pharmacology of Agents Used in Hyperlipidemia
HYPERLIPIDEMIAS  Conditions in which the concentrations of cholesterol or triglyceride carrying lipoproteins exceed arbitrary normal limits.
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 29 Antilipemic Drugs.
The Antihyperlipidemic Medications l Classifications of Lipoproteins – Chylomicrons l Formed in the mucosal cells of the gut l Protein coated dietary lipids.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.
Kirk Mykytyn, Ph.D. Department of Pharmacology
Department of Family & Community Medicine
Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.
Hyperlipidemia Hyperlipoproteinemia Hyperlipoproteinemia (cholesterol, Triglyceride, LDL-C, VLDL) Lead to atherosclerosis and Coronary artery disease.
ANTIHYPERLIPIDEMIC DRUGS
Hperlipidemia:- Treatment and Management Presented by:- Dr. Tewari.
Antihyperlipidemia.
Antihyperlipidemic Drugs Hyperlipidemias. Hyperlipoproteinemias. Hyperlipemia. Hypercholestrolemia. Direct relationship with acute pancreatitis and atherosclerosis.
ANTIHYPERLIPIDAEMIC DRUGS
Management & Medications  Diet, weight loss and drug therapy are the mainstay of treatment, while exercise training is used as adjunctive therapy  Lipid-lowering.
Antihyperlipidemic drugs The clinically important lipoproteins are LDL low density lipoprotein, VLDL very low density lipoprotein, HDL high density lipoprotein.
Case 15 Andrea De Mesa. Patient history A 44 y/o male, single, undergoes cardiovascular screening on advice of his attending physician. He is a smoker.
Step 3 P-treatment: Drug Class Selection. Pharmacological and Non- Pharmacological Management Dyslipidemia drug therapyLifestyle modification Smoking.
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
Jiří Slíva, M.D. statins (inhibitors of HMG-CoA reductase) fibrates anion - exchange resins nicotinic acid group.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Antilipemic Drugs.
HLD Tx & AHA/ACC Guidelines
Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.
Management of Hyperlipoprotinaemia
1 HYPOLIPIDAEMICS or LIPID LOWERING DRUGS. 2 Hypolipidaemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
50 Drugs that Help Normalize Cholesterol & Triglyceride Levels
Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels.
Drugs Used in Hyperlipidemia
Antihyperlipidemic Drugs
Hypolipidemic Drugs Classification:
Drugs for hyperlipidemia
Hyperlipidemias.
Drugs for Lipid Disorders
Statins induced myopathy
Drugs for hyperlipidemia
Anti-Hypercholesterolemic Agents
By: Dr Israa Omar MBBS, MRCP, MSc pharmacology
Drugs for Hyperlipidemia
Formative Test.
Anti-Hypercholesterolemic Agents  Biosynthesis and Metabolism of Cholesterol  What is arteriosclerosis? - Link between arteriosclerosis and cholesterol.
18 Dyslipidemia Lect -2- Dr.Hozan.
Antihyperlipidemic Drugs
Anti-Hypercholesterolemic Agents
Drugs for Hyperlipidemias
Biosynthesis and Metabolism of Cholesterol
Antilipidaemic agents
Antihyperlipidemic Drugs
Cardiovascular System
Major classes of drugs to reduce lipids
Drugs for Hyperlipidemia
Lipoproteins   Macromolecular complexes in the blood that transport lipids Apolipoproteins   Proteins on the surface of lipoproteins; they play critical.
Hyperlipidemia (Hyperlipoproteinaemia) (Dyslipidemia) By Ahmed M
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Presentation transcript:

أبدا لم يفت الاوان لكي تبدأ Drugs for hyperlipidemia SUMMARY. (Slide 2) MCQs. (Slide 3 and 4) SAQ. (Slide 5) أبدا لم يفت الاوان لكي تبدأ

Cholestyramine Colestipol Colesevelam Target Class Drug Action ADRs Effect (%change) Notes Exogenous Cholesterol Bile Acid sequestrants Cholestyramine Colestipol Colesevelam Form an insoluble complex with the bile acids and salts, preventing their reabsorption from the intestine and disrupting the enterohepatic circulation of bile acids. GI distress, constipation, decreased absorption of other drugs (Statins, Ezetimibe Chlothiazides, Digoxin, Warfarin) Colesevelam does not interfere with absorption of other drugs  LDL  HDL No change in triglycerides Contraindications: 1- Complete biliary obstruction 2- Chronic constipation 3-Severe hypertriglyceridemia (TG >400 mg/dL) Cholesterol absorption inhibitor Ezetimibe Ezetimibe reduces C absorption. Therefore, ezetimibe reduces the flux of C from the intestine to the liver. Not common GIT disturbance, headache, fatigue, artheralgia & myalgia  LDL( 14-18),  HDL (1-3) Triglyceride (2) Monotherapy: primary prevention of low risk CHD. Combination therapy: safe: with statins or fibrates endogenous cholesterol Statins (HMG-Co A Reductase Inhibitors) Simvastatin Lovastatin Atorvastatin Pravastatin Rosuvastatin potent competitive inhibitors of HMG-CoA reductase Common: Headache , myalgia, fatigue, GI intolerance, and flu-like symptoms Hepatotoxicity, Teratogenicity. Muscle aches, or weakness associated with an elevation of creatine kinase (CK) released from muscles, are the best indicator of statin-induced myopathy LDL 18-55% HDL 5-10% TG & VLDL 10-30% It is important to check CK & liver enzymes regularly upon administration of statins. Niacin (Nicotinic Acid) In adipose tissue: it binds to adipose nicotinic acid receptors In liver:inhibits hepatocyte diacylglycerol acyltransferase-2 In plasma : it increase LPL activity Flushing (+aspirin) Hyperglycemia, Hyperuricemia, GI distress, hepatotoxicity LDL (15-30), HDL (15-35)  Triglyceride (20-50) Contra-indications Gout – Peptic ulcer – Hepatotoxicity – Diabetes mellitus Fibrates Clofibrate Fenofibrate Gemfibrozil They increase gene transcription for lipoprotein lipase (LPL) leading to increased catabolism of TG in VLDL and chylomicrons Dyspepsia, gallstones, myopathy LDL (5-20), HDL (10-20) Triglyceride (20-50) Pregnant or nursing women ,Renal impairment,Gall-bladder disease,In alcoholics

Online Quiz .. https://www.onlineexambuilder.com/pharmacology-anti-hyperlipidemia/exam-144715 MCQs Q1: Which one of the following drugs binds bile acids in the intestine, thus preventing their return to the liver via the enterohepatic circulation? A) Niacin. B) Fenofibrate. C) Cholestyramine. D) Fluvastatin. Q2: A 62-year-old female with hyperlipidemia and hypothyroidism. Her current medications include cholestyramine and levothyroxine (thyroid hormone). What advice would you give to her to avoid a drug interaction between her cholestyramine and levothyroxine? A) Stop taking the levothyroxine as it can interact with cholestyramine. B) Take levothyroxine 1 hour before cholestyramine on an empty stomach. C) Switch cholestyramine to colestipol as this will eliminate the interaction. D) Take levothyroxine and cholestyramine at the same time to minimize the interaction. Q3: Which of the following patient populations is more likely to experience myalgia (muscle pain) or myopathy with use of HMG CoA reductase inhibitors? A) Patients with diabetes mellitus. B) Patients with renal insufficiency. C) Patients with gout. D) Patients with hypertriglyceridemia. Q4: Which one of the following drugs decreases cholesterol synthesis by inhibiting the enzyme 3-hydroxy-3- methylglutaryl coenzyme A reductase? A) Fenofibrate. B) Niacin. C) Cholestyramine. D) Lovastatin. Q5: A 42-year-old man who was started on niacin sustained-release tablets 2 weeks ago for elevated triglycerides and low HDL levels. He is complaining of an uncomfortable flushing and itchy feeling that he thinks is related to the niacin. Which of the following options can help him manage this adverse effect of niacin therapy? A) Administer aspirin 30 minutes prior to taking niacin. B) Administer aspirin 30 minutes after taking niacin. C) Increase the dose of niacin to 1000 mg. D) Change the sustained-release niacin to immediate-release niacin. Q6: A 72-year-old female who is treated for hyperlipidemia with Pravastatin for the past 6 months.. Her physician wishes to add an additional agent to block absorption of exogenous cholesterol. Which of the following choices is the best option? A) Niacin. B) Colesevelam. C) Gemfibrozil. D) Ezetimibe. 6:D 5:A 4:D 3:B 2:B 1:C Answers

Cont…. MCQs A) Niacin. B) Statins . C) Colestipol .D) Ezetimibe. Q7: Patient comes into the ER with gallstones, after further investigations You find out that he is on drugs to treat his hyperlipidemia. Which of the following drugs could have caused his gall stones? A) Niacin. B) Fenofibrate C) Ezetimibe D) Colesevelam Q8: A 65-year-old man who presents to his physician for management of hyperlipidemia. His most recent lipid panel reveals an LDL cholesterol level of 136 mg/ dL and very low HDL cholesterol about 28 mg/ dL. His physician wishes to begin treatment to increase his HDL cholesterol levels. Which of the following therapies is the best option to increase HDL cholesterol levels? A) Colesevelam. B) Niacin. C) Simvastatin. D) Ezetimibe. Q9: Patient with diabetes has hyperlipidemia, Which drug of the following can not be used in his case due the risk of development of Hyperglycemia? A) Niacin. B) Statins . C) Colestipol .D) Ezetimibe. Q10: Patient with hypercholesterolemia taking a combination of two anti hyperlipidemic drugs, After 4 days the patient complaining of sever myalagia and increase in creatine kinase. Which drugs did this patient use? A) Cholestyramine & Lovastatin. B) Fenofibrate & Ezetimibe. C) Lovastatin & Fenofibrate. D) niacin & Ezetimibe. Q11: Patient went to the hospital to check his blood cholesterol level and he had an increase in LDL, The doctor prescribes one of the an4 hyperlipidemia drugs with vitamins D and E supplement, What is the most likely drug the doctor prescribed? A) Statins. B) Colestipol. C) Ezetimibe. D) Nicotinic acid Q12: A 72-year-old male who is treated for hyperlipidemia with anti-hyperlipidemic agent for the past 6 months. He also has a history of sever constipation. His most recent lipid panel shows an LDL cholesterol level of 131 mg/dL, and high level of triglycerides of 510 mg/dL, and there is no change in HDL cholesterol. Which of the following drugs did this patient use? A) Ezetimibe. B) Niacin. C) Colestipol. D) Gemfibrozil. Q13: Which one of the following is the most common side effect of anti-hyperlipidemic drug therapy? A) Elevated blood pressure. B. Gastrointestinal disturbance. C. Neurologic problems. D. Heart palpitations. 13:B 12:C 11:B 10:C 9:A 8:B 7:B Answers

SAQ A 72-year-old male who is treated for hyperlipidemia with high-dose atorvastatin for the past 6 months. He also has a history of renal insufficiency. His most recent lipid panel shows an LDL cholesterol level of 131 mg/dL, triglycerides of 510 mg/dL, and HDL cholesterol of 30 mg/dL. Q1: What is the mechanism of action of Atorvastatin ? It is an example of Statins which are potent competitive inhibitors of (HMG-CoA) reductase which is an important enzyme in cholesterol synthesis in the liver. Q2:Is there anything special about Atorvastatin?  Yes, it has long half-life (14 hours) so we can take it at any time of the night . Q3: What are the most serious side effect of statin group, that we have to be aware of them by frequent lab investigation ? Hepatotoxicity, Myopathy Q4: If his physician wishes to add an additional agent for his hyperlipidemia. Which of choices is the best option in his case ? why ? Niacin (nicotinic acid), because it is the most effective medication for increasing HDL cholesterol levels and it has positive effects on the complete lipid profile. So it is useful for patients with mixed dyslipidemias. Q5: list three of contraindication for this drug ^^? 1-Gout. 2-Peptic ulcer.. 3-Diabetes mellitus. Q6: why we can not use any drug from Resins group in this case ? Because he has high level of TG and The bile acid binding resins can raise triglycerides more and more which will worse his situation. Q7: why we can not use any drug from Fibrate group in this case ? He has a history of renal insufficiency so we can not combine the fibrate with statin because the incidence of myopathy may increase, he also may develop Rhabdomyolysis.

Editing file